| [1] |
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation[J]. J Hepatol, 2016, 64(2): 433-485.
|
| [2] |
Neves DB, Rusi MB, Diaz LG, et al. Primary graft dysfunction of the liver: definitions, diagnostic criteria and risk factors[J]. Einstein (Sao Paulo), 2016, 14(4): 567-572.
|
| [3] |
Verhelst X, Geerts A, Jochmans I, et al. Glycome patterns of perfusate in livers before transplantation associate with primary nonfunction[J]. Gastroenterology, 2018, 154(5): 1361-1368.
|
| [4] |
Vertemati M, Sabatella G, Minola E, et al. Morphometric analysis of primary graft non-function in liver transplantation[J]. Histopathology, 2005, 46(4): 451-459.
|
| [5] |
Uemura T, Randall HB, Sanchez EQ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience[J]. Liver Transpl, 2007, 13(2): 227-233.
|
| [6] |
Linares-Cervantes I, Echeverri J, Cleland S, et al. Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts[J]. Am J Transplant, 2019, 19(11): 2991-3005.
|
| [7] |
Al-Freah M, McPhail M, Dionigi E, et al. Improving the diagnostic criteria for primary liver graft nonfunction in adults utilizing standard and transportable laboratory parameters: An outcome-based analysis[J]. Am J Transplant, 2017, 17(5): 1255-1266.
|
| [8] |
Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4): 783-790.
|
| [9] |
Johnson SR, Alexopoulos S, Curry M, et al. Primary nonfunction (PNF) in the MELD Era: An SRTR database analysis[J]. Am J Transplant, 2007, 7(4): 1003-1009.
|
| [10] |
Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers[J]. Gastroenterology, 2003, 124(1): 91-96.
|
| [11] |
Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3 200 liver transplantations over two decades: A single-center experience[J]. Ann Surg, 2005, 241(6): 905-916; discussion 916-918.
|
| [12] |
Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4 000 consecutive patients at a single center[J]. Ann Surg, 2000, 232(4): 490-500.
|
| [13] |
Kahn J, Pregartner G, Avian A, et al. The Graz liver allocation strategy-impact of extended criteria grafts on outcome considering immunological aspects[J]. Front Immunol, 2020, 11: 1584.
|
| [14] |
Croome KP, Mathur AK, Mao S, et al. Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis[J]. Am J Transplant, 2020, 20(9): 2449-2456.
|
| [15] |
Máthé Z, Paul A, Molmenti EP, et al. Liver transplantation with donors over the expected lifespan in the model for end-staged liver disease era: is Mother Nature punishing us?[J]. Liver Int, 2011, 31(7): 1054-1061.
|
| [16] |
Golse N, Guglielmo N, El Metni A, et al. Arterial lactate concentration at the end of liver transplantation is an early predictor of primary graft dysfunction[J]. Ann Surg, 2019, 270(1): 131-138.
|
| [17] |
He X, Guo Z, Zhao Q, et al. The first case of ischemia-free organ transplantation in humans: A proof of concept[J]. Am J Transplant, 2018, 18(3): 737-744.
|
| [18] |
Zhang Z, Tang Y, Zhao Q, et al. Association of perfusion characteristics and posttransplant liver function in ischemia-free liver transplantation[J]. Liver Transpl, 2020, 26(11): 1441-1454.
|